The media mogul is being criticized by some for statements she made about thin people on the latest episode of her podcast.
Oprah Winfrey has shared the surprising discovery she made about "thin people" due to her experience with Ozempic.
Oprah Winfrey is opening up about her experience using weight-loss drugs. The media mogul is sharing some of the realizations she has found after being under an undisclosed GLP-1, which is a type 2 diabetes medication that results in weight loss.
American chat show host Oprah Winfrey came under fire last year after finally confessing her weight-loss was thanks to Ozempic - and now she has come to a major realisation
The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That changed after a special on weight loss with experts and clinicians that she taped in July 2023. The panel discussion left her with her “biggest aha moment” about the medication.
The media mogul's comments about weight loss drugs and "thin people" have stirred intense reactions across social media platforms.
On the latest episode of her podcast, Oprah Winfrey opened up about how her opinion of “thin people” changed after she was able to lose weight herself with the help of weight loss medications.
All these years I thought that thin people — those people — just had more willpower,” Winfrey said on her podcast.
Oprah Winfrey has recently shared her two cents on thin people after the use of weight loss drug Ozempic.On January 21, Oprah, who is now 72 kg, revealed what it’s like to take a GLP-1
Oprah Winfrey is one of the name in the long list of A-listers, who have turned to medication to help them in their weight loss journey.During a conversation with Dr. Ania Jastreboff on her podcast, The Oprah Show,
Reflecting on her public journey, Winfrey shared the emotional toll of tabloid exploitation and societal judgment.
Oprah Winfrey has changed her perceptions of "thin people" after taking weight loss medication. The 70-year-old talk show host has seen her